Curis | CRIS - Należności Handlowe





Należności Handlowe Zmiana Data
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.14B 432M 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
CSL USD 4.32B 1.35B 2025-12
Curis USD 2.55M 400K 2024-06
Eli Lilly USD 21.18B 1.02B 2026-03
Exelixis USD 328.95M 42.03M 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Merck USD 11.78B 345M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
Takeda JPY 876.35B 118.43B 2026-03
TG Therapeutics USD 392.05M 86.42M 2026-03
Verastem USD 9.01M 8.81M 2025-12
Xoma USD 14.78M 4.96M 2024-06